Fear of the unknown is a normal reaction. I suppose I should state from the start I have little information that is not general knowledge. I felt it was worth commenting on some of the items posted above.
I do not think Inlight was profitable but suspect that AC was probably viable on it's own. I don't know why PriMed pulled the plug but suspect they needed capital.
AC has improved under the aegis of PriMed, perhaps not as much as we would have liked but much of that was due to government requirements. While it's easy for those of us who had already purchased AC to ignore Meaningless Use, it's a reality they could not afford to ignore.
It would appear that Constellation has a lot of different companies under their umbrella. That would then mean they might have resources that PriMed did not or that they could destroy AC if they wished. I'm not familiar with GEMMs as an EMR but it is client server like AC and seems to be aimed at Cardiologists. The Caretracker software also has 2 EMR (one for Ob/Gyn) and a PM side. How much interaction is their between their "divisions"? My suspicion is that AC's user base is larger than any of their 3 EMRs and possibly the only one aimed at general outpatient medicine. It could be a good fit (or they could be buying the competition to destroy it). Only time will tell.
If AC without Inlight is profitable, as I suspect, it might warrant benign neglect: Allow it to move forward as it has been doing without a lot of interference. But then again, what are their goals and motives?
After I finished the above post, I found this on Constellation's website about acquisitions:
http://www.csisoftware.com/about-us/being-acquired/This does sound encouraging.........
